-transparent.png){kind=logo}
Eighteen patients with pituitary dwarfism were treated for 1 7/12 to 6 years with human growth hormone (hGH) at a dose of 0.19--0.62 unit (U) per kg of body weight per week. The mean increment in height was 2.0 +/- 0.4 and 8.8 +/- 0.5 cm/year before and the first year after treatment of hGH, respectively. A significant positive correlation was observed between serum levels of somatomedin A and growth rate, espcially in children with bone age below 10 and a duration of treatment of less than one year (r = 0.66, P less than 0.005). Long-term treatment with hGH was accompanied by a decreasing response. However, the serum levels of somatomedin A did not decrease significantly. Therefore, decreased growth increment in these situations was not due to decreased serum levels of somatomedin A.
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
October 1984,
Nihon Naibunpi Gakkai zasshi,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
March 1972,
Acta endocrinologica,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
January 1968,
Israel journal of medical sciences,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
January 1970,
Acta paediatrica Scandinavica. Supplement,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
October 1978,
Ceskoslovenska pediatrie,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
August 1970,
Endocrinologia japonica,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
April 1984,
Endocrinologia japonica,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
October 1980,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
October 1981,
Revista clinica espanola,
K Takano, and
N Hizuka, and
K Shizume, and
Y Hasumi
January 1986,
Acta endocrinologica. Supplementum,
